Commure, an enterprise healthcare technology company, has raised $200 million in growth financing from General Catalyst’s Customer Value Fund (CVF). The funding will support the expansion of Commure’s full-stack AI platform, which includes ambient clinical documentation, AI-powered revenue cycle management (RCM), and practice management tools. With more than 130 health systems nationwide using its platform, Commure serves hundreds of thousands of clinicians and automates billions of dollars in annual RCM transactions. The company recently initiated the country’s largest ambient AI deployment at HCA Healthcare and has doubled its annual recurring revenue for three consecutive years. “This funding lets us accelerate our reach and impact in healthcare with capital aligned to performance,” said Tanay Tandon, CEO of Commure.
The CVF financing structure allows Commure to scale growth without equity dilution or added financial risk. The investment will drive faster product development, implementation, and go-to-market execution, enabling health systems to adopt the platform more efficiently. Commure's portfolio includes real-time clinical note generation, autonomous coding, billing automation, and AI-driven patient engagement tools. Pranav Singhvi, Managing Director and Co-Head of CVF at General Catalyst, shared, “Commure is growing with exceptional efficiency and clarity of execution. We’re happy to partner with a company that turns customer momentum into durable growth.”
